Prurigo nodularis, characterized by intensely itchy ... oral medications, and phototherapy, all aimed at providing effective management of PN symptoms and improving patient well-being.

The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib and abrocitinib.

1 Additional data from both the ARCADIA program in atopic dermatitis, as well as from the OLYMPIA open-label extension study in prurigo nodularis will be presented at RAD 2025, reinforcing ...

The upcoming Conversations in Dermatology 2025 event will discuss best practices for the treatment of chronic spontaneous urticaria, prurigo nodularis, and psoriasis.

2 Two-year data from a long-term extension study of Nemluvio in prurigo nodularis will also be presented later in June at the International Congress of Dermatology "With Nemluvio now being ...

9 IL-31 is a neuroimmune cytokine that drives itch and is involved in inflammation and skin barrier dysfunction in both atopic dermatitis and prurigo nodularis, and fibrosis in prurigo nodularis.

for the treatment of prurigo nodularis and chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications. Haduvio is nalbuphine’s oral extended-release ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

The phototherapy lamps market has been witnessing consistent growth due to increasing global health awareness and the rising demand for non-invasive treatment methods. These specialized lamps, used ...